Nanoparticle Shows Promise for ALS Nanoparticle Shows Promise for ALS
A novel treatment for amyotrophic lateral sclerosis that would represent a novel mechanism of action showed signs of efficacy when used with riluzole in a phase 2 trial.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 7, 2022 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news
Ronnie Corbett: Star's secret motor neurone diagnosis left him needing '24-hour care'
RONNIE CORBETT sadly passed away aged 85 back in March 2016. Just after his death, Corbett's devoted wife revealed more about the entertainer's ill health and his amyotrophic lateral sclerosis diagnosis that came as a complete shock to them both. (Source: Daily Express - Health)
Source: Daily Express - Health - April 2, 2022 Category: Consumer Health News Source Type: news
FDA Advisory Panel Narrowly Votes Against New ALS Drug
THURSDAY, March 31, 2022 -- In a close vote, an advisory panel for the U.S. Food and Drug Administration decided not to recommend the approval of an experimental drug for amyotrophic lateral sclerosis (ALS).
The panel ' s decision had been closely... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 31, 2022 Category: Pharmaceuticals Source Type: news
FDA Advisory Panel Rejects Novel ALS Drug FDA Advisory Panel Rejects Novel ALS Drug
A US Food and Drug Administration advisory committee is unconvinced by that a new drug for amyotrophic lateral sclerosis is effective.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 31, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
New ALS Treatment, AMX0035, Lacks Evidence of Benefit, FDA Panel Finds
With a 6-4 vote, the group of independent advisers to the agency narrowly concluded that results from another clinical trial are needed to assess whether the therapy, called AMX0035, can help patients. (Source: NYT Health)
Source: NYT Health - March 30, 2022 Category: Consumer Health News Authors: Pam Belluck Tags: your-feed-science Drugs (Pharmaceuticals) Clinical Trials Amyotrophic Lateral Sclerosis Research Placebos your-feed-healthcare Source Type: news
FDA Reviewers Give Thumbs Down to New ALS Drug
TUESDAY, March 29, 2022 -- Despite months of intense lobbying by patient advocates, federal health officials on Monday posted a largely negative review of an experimental drug for amyotrophic lateral sclerosis (ALS).
In an analysis of Amylyx... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 29, 2022 Category: Pharmaceuticals Source Type: news
Stakes Are High Ahead of FDA Panel Vote on ALS Drug
MONDAY, March 28, 2022 -- Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for amyotrophic lateral sclerosis (ALS), with a decision expected this week.
The push to approve the drug, so far... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 28, 2022 Category: Pharmaceuticals Source Type: news
Stakes Are High Ahead of FDA Panel Vote on ALS Drug
MONDAY, March 28, 2022 -- Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for the deadly neurological disease ALS (amyotrophic lateral sclerosis), with a decision expected this week.
The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 28, 2022 Category: General Medicine Source Type: news
Brain Implant Allows Fully Paralyzed Patient to Communicate Brain Implant Allows Fully Paralyzed Patient to Communicate
An experimental brain implant has allowed a man with amyotrophic lateral sclerosis who was unable to speak or move to communicate.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - March 24, 2022 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news
Brain Implant Allows Totally Paralyzed Patient to Communicate Brain Implant Allows Totally Paralyzed Patient to Communicate
An experimental brain implant has allowed a man with amyotrophic lateral sclerosis who was unable to speak or move to communicate.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 24, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Old drug, reworked data, new government push define company's attack on ALS
Ari Azhir set out more than 16 years ago to solve a mystery around deadly amyotrophic lateral sclerosis, the fatal muscle-wasting disease that killed baseball legend Lou Gehrig.
Now Azhir, her small Los Altos, California company, Neuvivo Inc., and its academic collaborators — including those at California Pacific Medical Center and the University of California, San Francisco — may be closer to an answer.
With a fresh look at data from two mid-stage clinical trials fr om years ago by a now-defunct… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 24, 2022 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Brain Implant Allows Fully Paralyzed Patient to Communicate
Letter by painstaking letter, a man in a completely locked-in state was able to formulate words and sentences using only his thoughts. (Source: NYT Health)
Source: NYT Health - March 23, 2022 Category: Consumer Health News Authors: Jonathan Moens Tags: Brain Computers and the Internet Amyotrophic Lateral Sclerosis ALS Assn Nature Communications (Journal) your-feed-science your-feed-health Research Coma Source Type: news
Brain Implant Helps Completely'Locked-In' Man Communicate
TUESDAY, March 22, 2022 -- Unable to move a single muscle, even to open your eyes. Completely locked into your own body, yet fully conscious and aware.
Lou Gehrig ' s disease— amyotrophic lateral sclerosis (ALS)— is a nightmare in its... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 22, 2022 Category: General Medicine Source Type: news
NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
PrimeC, a novel combination therapy, demonstrated efficacy and safety in Phase IIa study
Phase IIb study expected to commence Q2 2022
CAMBRIDGE, Mass., March 21, 2022 -- (Healthcare Sales & Marketing Network) -- NeuroSense Therapeutics Ltd. (Nasdaq:... Biopharmaceuticals, Neurology, FDA NeuroSense Therapeutics, PrimeC , amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 21, 2022 Category: Pharmaceuticals Source Type: news
John Q. Trojanowski Dies at 75; Changed Understanding of Brain Diseases
He was able to combine pathology and biochemistry to help figure out how and why people get diseases as disparate as Alzheimer ’s, Parkinson’s and A.L.S. (Source: NYT Health)
Source: NYT Health - March 1, 2022 Category: Consumer Health News Authors: Gina Kolata Tags: Deaths (Obituaries) Alzheimer ' s Disease Parkinson Amyotrophic Lateral Sclerosis University of Pennsylvania Research Proteins Trojanowski, John Q Lee, Virginia M-Y Tau proteins Source Type: news
